CNS Clinical Trials
Central Nervous System disorders are the most significant disease burden in high-income countries and they’re growing substantially in other regions as the standard of living increases. Additionally, this therapeutic area represents the second largest in the industry in terms of drug entries, including new indications and formulations in clinical development.
SPRI: Leading Experts in CNS Clinical Research
CNS disorders are SPRI’s therapeutic hallmark, leading us into the clinical research marketplace over 40 years ago. Our President and Chief Medical Officer, Nick Vatakis, MD, still remains active as a practicing investigator in CNS trials.
At SPRI Clinical Trials, our CNS team members are experts in a diverse spectrum of indications, including:
- Psychiatric disorders – Generalized Anxiety Disorder, Schizophrenia, Bipolar
- Neurological disorders – Alzheimer’s Disease, Multiple Sclerosis, stroke, pain
Contact SPRI today to learn more about our full suite of CRO services for CNS clinical trials. With strategic offices in the United States (New York and North Carolina), Ukraine, Russia, Georgia and Belarus and strategic partnerships in Western Europe and Australasia, we’re proud to provide comprehensive design, implementation and management for global CNS clinical studies.